Literature DB >> 30876857

Circular RNA Ttc3 regulates cardiac function after myocardial infarction by sponging miR-15b.

Lidong Cai1, Baozhen Qi2, Xiaoyu Wu1, Shi Peng1, Genqing Zhou1, Yong Wei1, Juan Xu1, Songwen Chen3, Shaowen Liu4.   

Abstract

The apoptotic death of cardiomyocytes critically contributes to cardiac remodeling after myocardial infarction (MI). Circular RNAs (circRNAs) are important regulators for a variety of biological functions. Circ-Ttc3 represents one of the top highest expressed circRNAs in the heart; however, its role in MI remains unknown. Herein, we found that circ-Ttc3 was markedly upregulated in the ischemic myocardium and the cardiomyocytes subjected to hypoxic insult. Forced expression of circ-Ttc3 in cardiomyocytes counteracted hypoxia-induced ATP depletion and apoptotic death, in sharp contrast to circ-Ttc3 knockdown. Accordingly, experiments with AAV9-cTnt-mediated knockdown of cardiac circ-Ttc3 in a rat model of MI recapitulated the in vitro findings, and showed the deterioration of cardiac dysfunction after MI. Furthermore, we identified that circ-Ttc3 sponged an endogenous miR-15b-5p to sequester and inhibit its activity, leading to the increased Arl2 expression. Conversely, knockdown of Arl2 partially abolished the beneficial effects of circ-Ttc3 overexpression on ATP production and apoptosis of cardiomyocytes. Thus, our findings revealed the cardioprotective role of circ-Ttc3 in MI. The miR-15b-Arl2 regulatory cascade underlies the protection against MI-induced cardiomyocyte apoptosis by circ-Ttc3.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiomyocyte apoptosis; Circular RNA; Myocardial infarction; miR-15b

Mesh:

Substances:

Year:  2019        PMID: 30876857     DOI: 10.1016/j.yjmcc.2019.03.007

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  44 in total

Review 1.  Insights into circular RNAs: their biogenesis, detection, and emerging role in cardiovascular disease.

Authors:  Zoe Ward; John Pearson; Sebastian Schmeier; Vicky Cameron; Anna Pilbrow
Journal:  RNA Biol       Date:  2021-03-28       Impact factor: 4.652

Review 2.  Interplay between circular RNA, microRNA, and human diseases.

Authors:  Bimaljeet Kour; Suruchi Gupta; Ravail Singh; Yengkhom Sophiarani; Prosenjit Paul
Journal:  Mol Genet Genomics       Date:  2022-01-27       Impact factor: 3.291

Review 3.  circRNA is a potential target for cardiovascular diseases treatment.

Authors:  Jie Ju; Ya-Nan Song; Xin-Zhe Chen; Tao Wang; Cui-Yun Liu; Kun Wang
Journal:  Mol Cell Biochem       Date:  2021-11-15       Impact factor: 3.396

Review 4.  Circular RNAs in cardiovascular diseases.

Authors:  Xiaohan Mei; Shi-You Chen
Journal:  Pharmacol Ther       Date:  2021-09-27       Impact factor: 12.310

Review 5.  Targeting circular RNAs as a therapeutic approach: current strategies and challenges.

Authors:  Alina T He; Jinglei Liu; Feiya Li; Burton B Yang
Journal:  Signal Transduct Target Ther       Date:  2021-05-21

6.  CircRNA 010567 plays a significant role in myocardial infarction via the regulation of the miRNA-141/DAPK1 axis.

Authors:  Qinge Zhao; Weichao Li; Wei Pan; Ziyao Wang
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

7.  Circ_0068655 Promotes Cardiomyocyte Apoptosis via miR-498/PAWR Axis.

Authors:  Qiaoying Chai; Mingqi Zheng; Le Wang; Mei Wei; Yajuan Yin; Fangfang Ma; Xinping Li; Haijun Zhang; Gang Liu
Journal:  Tissue Eng Regen Med       Date:  2020-08-06       Impact factor: 4.169

Review 8.  Circle the Cardiac Remodeling With circRNAs.

Authors:  Tiqun Yang; Tianxin Long; Tailai Du; Yili Chen; Yugang Dong; Zhan-Peng Huang
Journal:  Front Cardiovasc Med       Date:  2021-06-25

Review 9.  Circular RNAs as Competing Endogenous RNAs in Cardiovascular and Cerebrovascular Diseases: Molecular Mechanisms and Clinical Implications.

Authors:  Xue Min; Dong-Liang Liu; Xing-Dong Xiong
Journal:  Front Cardiovasc Med       Date:  2021-07-07

10.  Circular RNA mmu_circ_0005019 inhibits fibrosis of cardiac fibroblasts and reverses electrical remodeling of cardiomyocytes.

Authors:  Na Wu; Chengying Li; Li Zhong; Yafei Li; Bin Xu; Ying Xiang; Xiaoyue Jia; Zhiquan Yuan; Long Wu
Journal:  BMC Cardiovasc Disord       Date:  2021-06-21       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.